JP2000063207A - Control of allergen and formulation therefor - Google Patents

Control of allergen and formulation therefor

Info

Publication number
JP2000063207A
JP2000063207A JP10229581A JP22958198A JP2000063207A JP 2000063207 A JP2000063207 A JP 2000063207A JP 10229581 A JP10229581 A JP 10229581A JP 22958198 A JP22958198 A JP 22958198A JP 2000063207 A JP2000063207 A JP 2000063207A
Authority
JP
Japan
Prior art keywords
allergen
organic solvent
ethanol
allergens
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10229581A
Other languages
Japanese (ja)
Other versions
JP4247418B2 (en
Inventor
Shingo Fujii
真吾 藤井
Yoshio Izuhara
美穂 厳原
Shigeki Takagi
滋樹 高木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fumakilla Ltd
Original Assignee
Fumakilla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fumakilla Ltd filed Critical Fumakilla Ltd
Priority to JP22958198A priority Critical patent/JP4247418B2/en
Publication of JP2000063207A publication Critical patent/JP2000063207A/en
Application granted granted Critical
Publication of JP4247418B2 publication Critical patent/JP4247418B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To suppress adverse effects and simply remove a wide range of allergens such as a mite, a Japanese cedar pollen or a cockroach at a low cost without leaving toxic substances in an environment in order to suppress the onset of allergy by denaturing the allergens utilizing an organic solvent such as an alcohol and inactivating the allergens. SOLUTION: An organic solvent such as an alcohol (preferably the alcohols such as ethanol, methanol or propanol, hydrocarbons such as hexane, toluene or xylene or halogenated hydrocarbons, etc., such as chloroform or dichlorobenzene) is brought into contact with allergens by spraying such as an aerosol to thereby denature and inactivate the allergens and remove the allergens. Ethanol at 20-100 vol./vol.% concentration is more preferably utilized as the organic solvent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、アレルギー、アト
ピー、喘息等の予防技術に関し、特には、環境中のアレ
ルゲンを失活させる、あるいはアレルゲンを不溶化させ
るアレルゲン除去方法及び製剤に関する。
TECHNICAL FIELD The present invention relates to a preventive technique for allergy, atopy, asthma and the like, and more particularly to a method and a preparation for removing allergen that inactivates or insolubilizes allergens in the environment.

【0002】[0002]

【従来の技術】アレルギー患者数は年々増加傾向にあ
り、国内の患者は750万人ともいわれ、現在非常に大
きな問題となっている。アレルギー疾患の対策は、アレ
ルギー疾患者の治療と、アレルゲンそのもののを除去す
る方法とに分けられる。
2. Description of the Related Art The number of allergic patients is increasing year by year, and it is said that the number of patients in Japan is 7.5 million, which is currently a very serious problem. Countermeasures for allergic diseases can be divided into treatment of people with allergic diseases and methods of removing allergens themselves.

【0003】アレルギー疾患者の治療としては、ステロ
イド剤や抗ヒスタミン剤の投与が行われているが、効果
や副作用を考慮すると決して満足できるレベルではな
い。また、体質を改善する治療法も検討されているが、
その手法が確立されるまでには至っていない。一方、環
境中からアレルゲンを除去することはアレルギー発症の
予防に大変有効であるとの報告がある(アレルギー41
1405〜1412、THELANCET 336
895〜897)。環境中のアレルゲン密度を低下させ
るために、殺ダニ剤、殺菌剤および殺ダニ効果を謳った
掃除機、ふとん乾燥器等が市販されている。また、特開
昭61−44821号公報や特開平6−279273号
公報には、タンニン酸や類似構造を有する物質で環境を
処理することにより、アレルゲンを除去する方法が示さ
れている。
[0003] Steroids and antihistamines have been administered for the treatment of people with allergic diseases, but they are not at a satisfactory level in view of their effects and side effects. In addition, treatment methods to improve physical constitution are also being considered,
The method has not been established. On the other hand, it has been reported that removing allergens from the environment is very effective in preventing the development of allergies (Allergy 41
1405-1412, THELANCET 336
895-897). In order to reduce the allergen density in the environment, acaricides, bactericides, vacuum cleaners and futon dryers, etc., which have an acaricidal effect are commercially available. Further, JP-A-61-44821 and JP-A-6-279273 disclose a method of removing an allergen by treating the environment with tannic acid or a substance having a similar structure.

【0004】[0004]

【発明が解決しようとする課題】前記に挙げた商品はダ
ニやカビそのものの増殖の抑制には有効であるが、アレ
ルゲンはカビ本体やダニの死骸並びに排泄物に多く含ま
れているため、単にダニやカビを殺すだけでは室内のア
レルゲン量は低下しない。そのため、アレルギー発症を
抑制するには、これらのアレルゲンを除去させる必要が
ある。アレルゲンの除去するには掃除機による吸引やふ
とんたたき、クリーニング等で行うのが一般的である。
しかし、前記の方法を通常通り行ってアレルゲンを除去
するのは非常に困難で、最も効果の高いクリーニングに
おいても手間やコストがかかる(アレルギー40 43
9〜443)。また、タンニン酸等の物質で環境を処理
すると多価フェノール基が金属イオンとキレートを形成
し、特異的な定色反応が起こるため、壁や敷物等が着色
し、実使用に至るまでには解決すべき問題が山積してい
る。以上より、安価で簡便なアレルゲン除去方法が望ま
れている。
The above-mentioned products are effective in suppressing the growth of mites and molds themselves, but since allergens are contained in large amounts in the mold body, carcasses of mites and excrement, Just killing mites and molds does not reduce the amount of allergens in the room. Therefore, in order to suppress the onset of allergies, it is necessary to remove these allergens. The removal of allergens is generally performed by suction with a vacuum cleaner, futon tapping, cleaning, or the like.
However, it is very difficult to remove the allergen by performing the above-mentioned method normally, and it takes time and cost even in the most effective cleaning (allergy 4043).
9-443). Also, when the environment is treated with a substance such as tannic acid, the polyhydric phenol group forms a chelate with the metal ion and a specific color reaction occurs, causing the walls and rugs to be colored and before actual use. There are many problems to be solved. From the above, an inexpensive and simple allergen removal method is desired.

【0005】本発明は、前記従来技術の問題点を改善・
解決するものであり、アレルギーの発症予防に効果を有
するのみならず、副作用を抑え環境中に有害物を残留さ
せず、しかも広範囲なアレルゲンに利用できる新規技術
を提供するものである。
The present invention improves the above-mentioned problems of the prior art.
The present invention provides a novel technique which is not only effective in preventing the development of allergies, but which suppresses side effects, does not leave harmful substances in the environment, and can be used for a wide range of allergens.

【0006】[0006]

【課題を解決するための手段】本発明者らは、前記課題
を解決するために鋭意研究した結果、タンパク質で構成
されているアレルゲンはエアゾール等の吹付けによって
有機溶剤を接触させることで、その生理活性に変化を来
すことを発見した。また、溶媒蒸気においても同様の効
果があることも明確となった。
Means for Solving the Problems As a result of intensive studies for solving the above-mentioned problems, the present inventors have found that an allergen composed of a protein is brought into contact with an organic solvent by spraying with an aerosol or the like. It was discovered that there is a change in physiological activity. It was also clarified that the same effect can be obtained with solvent vapor.

【0007】なお、前記有機溶剤は、エタノール、メタ
ノール、プロパノール等のアルコール類、ヘキサン、ト
ルエン、キシレン等の炭化水素類、クロロホルム、ジク
ロロベンゼン等のハロゲン化炭化水素類、フェノール、
クレゾール等のフェノール類、ジエチルエーテル、テト
ラヒドロフラン等のエーテル類、酢酸、オレイン酸等の
カルボン酸類、アセトニトリル、アニリン等の窒素化合
物、酢酸エチル等のエステル、アセトン、メチルエチル
ケトン等のケトン類、ジメチルスルホキシド等の硫黄化
合物類より選ばれた1種または2種以上の混合物を利用
した場合に、きわめて良好な効果があらわれる。
The organic solvent includes alcohols such as ethanol, methanol and propanol, hydrocarbons such as hexane, toluene and xylene, halogenated hydrocarbons such as chloroform and dichlorobenzene, phenol,
Phenols such as cresol, ethers such as diethyl ether and tetrahydrofuran, carboxylic acids such as acetic acid and oleic acid, nitrogen compounds such as acetonitrile and aniline, esters such as ethyl acetate, ketones such as acetone and methyl ethyl ketone, dimethyl sulfoxide and the like A very good effect appears when one or a mixture of two or more selected from sulfur compounds is used.

【0008】また、前記アレルゲンは、環境中に存在す
るダニ、スギ花粉、ゴキブリ、カビ等のアレルゲンを対
象にすると著しい効果がある。
Further, the above-mentioned allergen has a remarkable effect when targeting allergens such as mites, cedar pollen, cockroaches and molds existing in the environment.

【0009】また、有機溶剤を利用したことで、特異的
な定色反応が起こるのを防止し、着色等の汚染をなくす
ことができる。
Further, by using the organic solvent, it is possible to prevent a specific color-matching reaction from occurring and to prevent contamination such as coloring.

【0010】[0010]

【発明の実施の形態】以下に実施例を挙げて本発明を説
明する。しかし、本発明がこれらの実施例に限定される
ものではないことはいうまでもない。
BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described below with reference to Examples. However, it goes without saying that the present invention is not limited to these examples.

【0011】<実施例1>実施例1は溶剤に浸漬した場
合であり、その効果は以下の通りである。ダニ培養物か
ら分離、凍結乾燥したダニ虫体1mgを0、50、10
0v/v%エタノール溶液1mlに10分間浸漬し、E
LISA法にてアレルギー患者IgE(免疫グロブリン
E)との結合能を調査した。このELISA法は次の通
りである。
<Example 1> Example 1 is a case of immersion in a solvent, and the effects are as follows. Freeze-dried 1 mg of mite bodies isolated from mite cultures gave 0, 50, 10
Immerse in 1 ml of 0 v / v% ethanol solution for 10 minutes, and
The binding ability with IgE (immunoglobulin E) of allergic patients was investigated by the LISA method. This ELISA method is as follows.

【0012】重炭酸塩緩衝液(Bicarbonate
buffer)で10μg/mlに希釈した抗原液を
マイクロタイタープレート(Falcon3912,B
ecton Dickinson and Co.)の
ウェルに50μl加え、25℃で2時間静置して抗原の
固定化を行った。PBST(PBS containi
ng 0.05%Tween20)、PBSで洗浄後、
200μlの阻止緩衝液(Blocking buff
er)(PBST,containing 5%ski
n milk)を加え、25℃で2時間静置した。再
び、PBST、PBSで洗浄後、PBSで4、8、16
倍に希釈したダニ喘息患者プール血清をそれぞれ50μ
lずつ加え、25℃で12時間静置した。PBST、P
BSで洗浄後、1000倍に希釈したアフィニティー分
離山羊抗体抗−(Affinity−isolated
Goat Antibodies anti−(Hu
man IgE epsilon chain))ビオ
チン抱合体(Biotinconjugate(BIO
SOURCE international))をプレ
ートにそれぞれ50μlずつアプライし、25℃で2時
間静置した。PBST、PBSで洗浄後、1000倍に
希釈したHPR−ストレプタヴィディン(HPR−st
reptavidin)(Zymed)を50μlアプ
ライし、25℃で1時間静置した。PBST、PBSで
洗浄後、100μlの発色液を加えて発色させ、450
nmで吸光度を測定した。
Bicarbonate buffer
The antigen solution diluted to 10 μg / ml with a buffer was added to a microtiter plate (Falcon 3912, B).
ecton Dickinson and Co. 50 μl was added to the well of (1) and allowed to stand at 25 ° C. for 2 hours to immobilize the antigen. PBST (PBS container
ng 0.05% Tween20), after washing with PBS,
200 μl of blocking buffer
er) (PBST, maintaining 5% ski)
(n milk) was added and the mixture was allowed to stand at 25 ° C. for 2 hours. Wash again with PBST and PBS, then with PBS 4, 8, 16
50 μm each of the mite asthma patient pool serum diluted twice
1 of each was added, and the mixture was allowed to stand at 25 ° C for 12 hours. PBST, P
Affinity-separated goat antibody anti- (Affinity-isolated) diluted 1000 times after washing with BS
Goat Antibodies anti- (Hu
man IgE epsilon chain)) biotin conjugate (Biotinconjugate (BIO)
SOURCE international)) was applied to the plate in an amount of 50 μl, and the plate was allowed to stand at 25 ° C. for 2 hours. After washing with PBST and PBS, 1000-fold diluted HPR-streptavidin (HPR-st
50 μl of reptavidin) (Zymed) was applied, and the mixture was allowed to stand at 25 ° C. for 1 hour. After washing with PBST and PBS, add 100 μl of coloring solution to develop color, and
Absorbance was measured in nm.

【0013】その結果を、溶剤に浸漬した場合の効果を
示す下記の表1及びエタノール浸漬処理におけるIgE
結合能(水処理区(水浸漬区)のIgE結合能を100
%とした結合能)を示す図1に示す。
The results are shown in Table 1 below, which shows the effect when immersed in a solvent, and IgE in the ethanol immersion treatment.
The binding ability (IgE binding ability of the water treatment area (water immersion area)) is 100.
The binding capacity (%) is shown in FIG.

【0014】[0014]

【表1】 [Table 1]

【0015】表1及び図1から明らかなように、50%
エタノール溶液によって結合能は水処理区(水浸漬区)
の40%まで低下した。本結果は、エタノールがアレル
ゲンに作用し、アレルギー患者lgEとの結合価を低下
させたかもしくはアレルゲンとマイクロプレートとの結
合性を低下させたことを示しており、従来の生理活性に
変化を来したことは明確である。
As is clear from Table 1 and FIG. 1, 50%
Water treatment area (water immersion area) shows binding ability with ethanol solution
Of 40%. This result indicates that ethanol acts on the allergen to reduce the valency of lgE for allergic patients or the binding of the allergen to the microplate, which changes the conventional physiological activity. That is clear.

【0016】<実施例2>実施例2は溶剤蒸気と接触さ
せた場合であり、その効果は以下の通りである。密閉容
器に0、8、22、100v/v%エタノール溶液を入
れ、十分容器内を飽和させた後、ダニ虫体1mgを取り
分けたガラスシャーレを入れ、25℃で10時間飽和エ
タノール蒸気と接触させた。
<Embodiment 2> Embodiment 2 is a case of contact with a solvent vapor, and the effects are as follows. Put 0,8,22,100 v / v% ethanol solution in a closed container, fully saturate the inside of the container, put a glass petri dish containing 1 mg of mite body, and contact with saturated ethanol vapor at 25 ° C for 10 hours. It was

【0017】その結果を、各抗原濃度における水処理区
を基準にしたヒスタミン遊離比率を示す下記の表2及び
エタノールを空間接触させたアレルゲンのヒスタミン遊
離率を示す図2、各抗原濃度における水処理区を基準に
したヒスタミン遊離比率を示す図3、50%ヒスタミン
遊離時の抗原濃度を示す図4にそれぞれ示す。
The results are shown in Table 2 below, which shows the histamine release rate based on the water treatment group at each antigen concentration, and FIG. 2 which shows the histamine release rate of the allergen that was in spatial contact with ethanol. Water treatment at each antigen concentration The histamine release ratio based on the plot is shown in FIG. 3, and the antigen concentration at 50% histamine release is shown in FIG. 4, respectively.

【0018】[0018]

【表2】 [Table 2]

【0019】図2から明らかなように、22%エタノー
ル溶液(気中エタノール濃度約70%)において最も活
性を低下させた。
As is clear from FIG. 2, the activity was most reduced in the 22% ethanol solution (about 70% ethanol concentration in the air).

【0020】また、表2及び図3から明らかなように、
活性低下の割合は抗原濃度が低いほど顕著で、最も効果
が現れたのは抗原濃度が0.05μg/mlのときで、
活性は5分の1に低下した。
Further, as is clear from Table 2 and FIG.
The lower the antigen concentration, the more remarkable the decrease in activity, and the most effective effect was when the antigen concentration was 0.05 μg / ml.
The activity was reduced by a factor of 5.

【0021】また、図4から明らかなように、ヒスタミ
ン遊離率(このヒスタミン遊離率の測定法については後
述する)が50%となる時に要する抗原濃度は、水処理
区では0.9μg/mlであったが、22%エタノール
処理区では2.1μg/mlであった。つまり、生体に
取り込まれた抗原量が2.3倍であるにも関わらず、抗
原としての活性は同じであったことになる。
Further, as is clear from FIG. 4, the antigen concentration required when the histamine release rate (the method for measuring the histamine release rate will be described later) is 50% is 0.9 μg / ml in the water treatment area. However, it was 2.1 μg / ml in the 22% ethanol treated group. In other words, the activity as an antigen was the same although the amount of the antigen taken into the living body was 2.3 times.

【0022】このようにエタノール溶液において濃度が
20v/v%〜100v/v%のときにアレルゲンをき
わめて効果的に失活させることができる。
In this way, the allergen can be deactivated extremely effectively when the concentration is 20 v / v% to 100 v / v% in the ethanol solution.

【0023】次に、ヒスタミン遊離率の測定法について
述べる。アレルギーは、好塩基球に結合しているIgE
抗体が抗原と結合することによって架橋され、好塩基球
からヒスタミンなどの化学伝達物質が放出されることで
発症する。そのため、アレルゲン活性が低下した抗原で
は、IgEとの結合が低下するので血球から遊離される
ヒスタミン量が低下する。そこで、抗原をエタノール処
理し、アレルギー患者血球からの遊離されるヒスタミン
量を高速液体クロマトグラフィーにより測定した。
Next, a method for measuring the histamine release rate will be described. Allergy is caused by IgE binding to basophils
It develops when antibodies bind to antigens and are crosslinked, and basophils release chemical mediators such as histamine. Therefore, an antigen with reduced allergen activity has reduced binding to IgE, and thus the amount of histamine released from blood cells is reduced. Therefore, the antigen was treated with ethanol and the amount of histamine released from the blood cells of allergic patients was measured by high performance liquid chromatography.

【0024】・エタノールの処理方法と抗原液の調製 ダニ培養物から分離、凍結乾燥したダニ虫体を1mgず
つ直径6cmのガラスシャーレに取り分け、密閉容器
(510ml)に0、8、22、100v/v%エタノ
ール溶液50mlを注ぎ、各濃度エタノールで十分容器
内を飽和させた。それぞれの容器内に抗原の入ったシャ
ーレを入れ、25℃で10時間放置することで、気中エ
タノールと接触させた。接触終了後、ハンクス緩衝液
(Hanks′buffer)を加えて懸濁し、抗原を
回収した。
-Method of treating ethanol and preparation of antigen solution 1 mg of mite bodies separated and freeze-dried from mite culture were separately placed in a glass petri dish having a diameter of 6 cm and placed in a closed container (510 ml) at 0, 8, 22, 100 v / 50 ml of v% ethanol solution was poured and the inside of the container was sufficiently saturated with ethanol of each concentration. A petri dish containing the antigen was placed in each container and left at 25 ° C. for 10 hours to bring it into contact with ethanol in the air. After the contact, Hanks' buffer was added and suspended to recover the antigen.

【0025】・アレルギー患者血球液の調製 アレルギー患者血液を1400rpm、15分間遠心分
離し、血球と血漿とに分けた。血球は5倍量のハンクス
緩衝液(Hanks′buffer)を加え、1400
rpm、15分間遠心分離し、上清を取り除いて3回洗
浄した。分離した血漿を洗浄した血球に加え、血球液と
して抗原刺激に用いた。
Preparation of blood cells of allergic patients Blood of allergic patients was centrifuged at 1400 rpm for 15 minutes to separate into blood cells and plasma. Blood cells were added with 5 times the amount of Hanks' buffer and added to 1400
After centrifugation at rpm for 15 minutes, the supernatant was removed and the plate was washed 3 times. The separated plasma was added to the washed blood cells and used as a blood cell fluid for antigen stimulation.

【0026】・遊離ヒスタミン量測定サンプルの調製 調製した抗原をハンクス緩衝液(Hanks′buff
er)で0.0005、0.001、0.005、0.
01、0.05、0.1、0.5、1、5、10、5
0、100μg/mlの濃度に希釈し、チューブに12
0μl分注した。各希釈液に前記アレルギー患者血球液
の調製で調製した血球液を120μl加え、37℃、3
0分間培養した。1400rpm、10分間遠心分離
後、上清120μlに60%HClOを12μl加
え、撹拌して蛋白成分を沈殿させた後、12000rp
m、10分間遠心分離した上清100μlを定量用試料
とした。同時に、血球液120μlに等量のハンクス緩
衝液(Hanks′buffer)を加えた後、60%
HClOを24μl加え、血球を破壊した後、120
00rpm、10分間遠心分離して上清100μlを全
ヒスタミン定量用試料とした。ブランクとして抗原刺激
しない場合のヒスタミン遊離量を測定した。
Preparation of a sample for measuring the amount of free histamine The prepared antigen was added to Hanks 'buffer (Hanks' buff).
er) 0.0005, 0.001, 0.005, 0.
01, 0.05, 0.1, 0.5, 1, 5, 10, 5
Dilute to a concentration of 0,100 μg / ml and add 12 to the tube.
0 μl was dispensed. To each diluted solution, 120 μl of the blood cell solution prepared in the preparation of the blood cell solution for allergy patients was added, and the mixture was incubated at 37 ° C. for 3
Incubated for 0 minutes. After centrifugation at 1400 rpm for 10 minutes, 12 μl of 60% HClO 4 was added to 120 μl of the supernatant, and the mixture was stirred to precipitate a protein component, and then 12000 rp
100 μl of the supernatant after centrifugation for 10 minutes was used as a quantitative sample. At the same time, after adding an equal volume of Hanks' buffer to 120 μl of blood cell solution, 60%
After adding 24 μl of HClO 4 to destroy blood cells, 120
Centrifugation was performed at 00 rpm for 10 minutes, and 100 μl of the supernatant was used as a sample for quantifying total histamine. As a blank, the amount of histamine released in the case of no antigen stimulation was measured.

【0027】・高速液体クロマトグラフィーによる遊離
ヒスタミン量の測定 ヒスタミン測定システムは日立製作所高速液体クロマト
グラフ分析システムを用いた。前処理カラムとしてWH
−C18(4.6mmID×50mmL)、分析用カラ
ムとしてCM−825(8.0mmID×75mm
L)、蛍光検出器としてF−1050を用い定量した。
Measurement of free histamine amount by high performance liquid chromatography As a histamine measurement system, a high performance liquid chromatograph analysis system manufactured by Hitachi Ltd. was used. WH as a pretreatment column
-C18 (4.6 mm ID x 50 mm L), CM-825 (8.0 mm ID x 75 mm) as an analytical column
L), and quantified using F-1050 as a fluorescence detector.

【0028】100μlの血球液中の全ヒスタミン量に
対する、各濃度の抗原刺激によって遊離されたヒスタミ
ン量(各サンプルヒスタミン量)の割合をヒスタミン遊
離率として以下の式で算出した。 ヒスタミン遊離率(%)=(各サンプルヒスタミン量−
ブランク)/(全ヒスタミン量−ブランク)×100
The ratio of the amount of histamine released by each concentration of antigen stimulation (the amount of histamine in each sample) to the total amount of histamine in 100 μl of blood cell fluid was calculated as the histamine release rate by the following formula. Histamine release rate (%) = (Histamine amount of each sample-
Blank) / (total histamine amount-blank) x 100

【0029】<実施例3>実施例3はアレルゲンを不溶
化した場合であり、その効果は以下の通りである。ダニ
培養物から分離、凍結乾燥したダニ虫体2mgを直径
3.5cmのプラスチックシャーレに取り分け、これに
0(水処理区)、50、75、100v/v%エタノー
ル溶液1mlを注ぎ、25℃8時間処理すると共に、シ
ャーレ内の水分を蒸発させた。1mlのPBSで抗原を
回収し、12000rpm、10分間遠心分離後、上清
である可溶性抗原液のタンパク量の測定を行った。この
タンパク量の測定は次の通りである。
<Example 3> Example 3 is a case where the allergen is insolubilized, and the effects thereof are as follows. 2 mg of mite bodies that had been separated from the mite culture and lyophilized were placed in a plastic Petri dish with a diameter of 3.5 cm. The water in the petri dish was evaporated along with the time treatment. The antigen was recovered with 1 ml of PBS, centrifuged at 12000 rpm for 10 minutes, and the amount of protein in the supernatant soluble antigen solution was measured. The measurement of this protein amount is as follows.

【0030】プロテインアッセイ試薬(バイオラッド
社)を用い、そのプロトコールに従ってブラッドフォー
ド(Brad ford)法にて各エタノール処理区の
可溶性タンパク量を測定した。即ち、10μlのサンプ
ルに対し、200μlの染色液を加え、撹拌した。15
分間室温で静置後、OD600nmの吸収を測定した。
Using a protein assay reagent (Bio-Rad), the amount of soluble protein in each ethanol-treated group was measured by the Bradford method according to its protocol. That is, 200 μl of the staining solution was added to 10 μl of the sample and stirred. 15
After standing at room temperature for a minute, the absorption at OD 600 nm was measured.

【0031】水処理区に対する各エタノール処理区の抗
原不溶化率を以下の式にて算出した。 抗原不溶化率(%)={1−(各処理区の測定値−ブラ
ンク)/(水処理区の測定値−ブランク)}×100
The antigen insolubilization rate of each ethanol-treated group with respect to the water-treated group was calculated by the following formula. Antigen insolubilization rate (%) = {1- (measured value of each treated section-blank) / (measured value of water treated section-blank)} × 100

【0032】その結果を、水処理区に対する各エタノー
ル処理区の抗原不溶化率を示す図5に示す。
The results are shown in FIG. 5 which shows the antigen insolubilization rate of each ethanol treatment group with respect to the water treatment group.

【0033】図5から明らかなように、75v/v%エ
タノールを処理した場合、約45%の不溶化が認められ
た。アレルゲンが不溶化することによって、粘膜の透過
率が低下すること、凝集沈殿効果によって環境中からの
アレルゲンの除去が容易になることが推測される。事
実、不溶化したアレルゲンは遠心分離時に低いGでも短
時間で回収され、一定のポアサイズの膜を使用して容易
に回収することができた。このようにアレルゲンを不溶
化させることで、アレルゲンの除去を容易にする。
As is clear from FIG. 5, when treated with 75 v / v% ethanol, about 45% insolubilization was observed. It is speculated that the insolubilization of the allergen reduces the permeability of the mucosa and facilitates the removal of the allergen from the environment by the effect of aggregation and precipitation. In fact, the insolubilized allergen was recovered in a short time even at low G during centrifugation, and could be easily recovered using a membrane of constant pore size. Insolubilizing the allergen in this manner facilitates removal of the allergen.

【0034】[0034]

【発明の効果】本発明の有機溶剤を主成分として単独で
もしくは共力剤を加えた形で利用したアレルゲン除去方
法及び製剤によれば、副作用を伴わない、環境中に有害
物質を残さず、かつタンニン酸等のキレート形成による
着色等の汚染もなく、アレルゲンを効果的に変性して失
活させることかできる。しかも、本発明は非常に簡便で
汎用性に富み、安価に環境中のアレルゲン量を低下させ
ることができると共に、アレルゲンを不溶化させること
で、アレルゲンの除去を容易にし、ひいてはアレルギー
の発症予防に有効である。
EFFECT OF THE INVENTION According to the method and preparation for removing allergen of the present invention, which contains the organic solvent as a main component, alone or in the form of adding a synergist, the allergen removing method does not leave side effects and does not leave harmful substances in the environment. Moreover, the allergen can be effectively denatured and deactivated without contamination such as coloring due to chelate formation of tannic acid or the like. Moreover, the present invention is very simple and versatile, and can reduce the amount of allergen in the environment at a low cost, by insolubilizing the allergen, facilitating the removal of the allergen, eventually effective in preventing the development of allergies. Is.

【0035】また、環境中に存在するダニ、スギ花粉、
ゴキブリ、カビ等のアレルゲンを対象にすると、著しい
効果を生じさせることができる。
In addition, mites and cedar pollen existing in the environment,
Targeting allergens such as cockroaches and molds can produce significant effects.

【0036】また、有機溶剤は、エタノール、メタノー
ル、プロパノール等のアルコール類、ヘキサン、トルエ
ン、キシレン等の炭化水素類、クロロホルム、ジクロロ
ベンゼン等のハロゲン化炭化水素類、フェノール、クレ
ゾール等のフェノール類、ジエチルエーテル、テトラヒ
ドロフラン等のエーテル類、酢酸、オレイン酸等のカル
ボン酸類、アセトニトリル、アニリン等の窒素化合物、
酢酸エチル等のエステル、アセトン、メチルエチルケト
ン等のケトン類、ジメチルスルホキシド等の硫黄化合物
類より選ばれた1種または2種以上の混合物を利用する
ことで、きわめて良好な効果を生じさせることができ
る。
The organic solvent includes alcohols such as ethanol, methanol and propanol, hydrocarbons such as hexane, toluene and xylene, halogenated hydrocarbons such as chloroform and dichlorobenzene, phenols such as phenol and cresol, Ethers such as diethyl ether and tetrahydrofuran, carboxylic acids such as acetic acid and oleic acid, nitrogen compounds such as acetonitrile and aniline,
By using one or a mixture of two or more selected from esters such as ethyl acetate, ketones such as acetone and methyl ethyl ketone, and sulfur compounds such as dimethyl sulfoxide, a very good effect can be produced.

【0037】また、有機溶剤は、濃度が20v/v%〜
100v/v%のエタノールを利用することで、アレル
ゲンをきわめて効果的に失活させることができる。
The organic solvent has a concentration of 20 v / v% to
By utilizing 100 v / v% ethanol, the allergen can be deactivated very effectively.

【図面の簡単な説明】[Brief description of drawings]

【図1】エタノール浸漬処理におけるIgE結合能を示
す図表。
FIG. 1 is a chart showing IgE binding ability in ethanol immersion treatment.

【図2】エタノールを空間接触させたアレルゲンのヒス
タミン遊離率を示す図表。
FIG. 2 is a diagram showing a histamine release rate of an allergen that is brought into spatial contact with ethanol.

【図3】各抗原濃度における水処理区を基準にしたヒス
タミン遊離比率を示す図表。
FIG. 3 is a chart showing the histamine release ratio based on the water treatment group at each antigen concentration.

【図4】50%ヒスタミン遊離時の抗原濃度を示す図
表。
FIG. 4 is a chart showing the antigen concentration when 50% histamine is released.

【図5】水処理区に対する各エタノール処理区の抗原不
溶化率を示す図表。
FIG. 5 is a chart showing the antigen insolubilization rate of each ethanol treatment group with respect to the water treatment group.

Claims (10)

【特許請求の範囲】[Claims] 【請求項1】 アルコール等の有機溶剤を利用したアレ
ルゲンを変性して失活させることを特徴とするアレルゲ
ン除去方法。
1. A method for removing allergen, which comprises deactivating the allergen by using an organic solvent such as alcohol.
【請求項2】 アルコール等の有機溶剤を利用したアレ
ルゲンを変性してアレルゲンを不溶化させることを特徴
とするアレルゲン除去方法。
2. A method for removing allergen, which comprises denaturing an allergen by using an organic solvent such as alcohol to denature the allergen.
【請求項3】 前記アレルゲンは、環境中に存在するダ
ニ、スギ花粉、ゴキブリ、カビ等のアレルゲンを対象に
したことを特徴とする請求項1または2記載のアレルゲ
ン除去方法。
3. The method for removing allergen according to claim 1, wherein the allergen is an allergen such as mites, cedar pollen, cockroaches, and molds existing in the environment.
【請求項4】 前記有機溶剤は、エタノール、メタノー
ル、プロパノール等のアルコール類、ヘキサン、トルエ
ン、キシレン等の炭化水素類、クロロホルム、ジクロロ
ベンゼン等のハロゲン化炭化水素類、フェノール、クレ
ゾール等のフェノール類、ジエチルエーテル、テトラヒ
ドロフラン等のエーテル類、酢酸、オレイン酸等のカル
ボン酸類、アセトニトリル、アニリン等の窒素化合物、
酢酸エチル等のエステル、アセトン、メチルエチルケト
ン等のケトン類、ジメチルスルホキシド等の硫黄化合物
類より選ばれた1種または2種以上の混合物を利用した
ことを特徴とする請求項1または2または3記載のアレ
ルゲン除去方法。
4. The organic solvent includes alcohols such as ethanol, methanol and propanol, hydrocarbons such as hexane, toluene and xylene, halogenated hydrocarbons such as chloroform and dichlorobenzene, phenols such as phenol and cresol. , Ethers such as diethyl ether and tetrahydrofuran, carboxylic acids such as acetic acid and oleic acid, nitrogen compounds such as acetonitrile and aniline,
4. One or a mixture of two or more selected from esters such as ethyl acetate, ketones such as acetone and methyl ethyl ketone, and sulfur compounds such as dimethylsulfoxide is used. Allergen removal method.
【請求項5】 前記有機溶剤は、濃度が20v/v%〜
100v/v%のエタノールを利用したことを特徴とす
る請求項1または2または3または4記載のアレルゲン
除去方法。
5. The organic solvent has a concentration of 20 v / v% to
The method for removing allergen according to claim 1, 2 or 3 or 4, wherein 100 v / v% of ethanol is used.
【請求項6】 アルコール等の有機溶剤を利用したアレ
ルゲンを変性して失活させることを特徴とするアレルゲ
ン除去製剤。
6. An allergen-removing preparation characterized by denaturing and deactivating an allergen using an organic solvent such as alcohol.
【請求項7】 アルコール等の有機溶剤を利用したアレ
ルゲンを変性してアレルゲンを不溶化させることを特徴
とするアレルゲン除去製剤。
7. An allergen-removing preparation, characterized by denaturing an allergen by denaturing an allergen using an organic solvent such as alcohol.
【請求項8】 前記アレルゲンは、環境中に存在するダ
ニ、スギ花粉、ゴキブリ、カビ等のアレルゲンを対象に
したことを特徴とする請求項6または7記載のアレルゲ
ン除去製剤。
8. The allergen-removing preparation according to claim 6, wherein the allergen is an allergen such as mites, cedar pollen, cockroaches, and molds existing in the environment.
【請求項9】 前記有機溶剤は、エタノール、メタノー
ル、プロパノール等のアルコール類、ヘキサン、トルエ
ン、キシレン等の炭化水素類、クロロホルム、ジクロロ
ベンゼン等のハロゲン化炭化水素類、フェノール、クレ
ゾール等のフェノール類、ジエチルエーテル、テトラヒ
ドロフラン等のエーテル類、酢酸、オレイン酸等のカル
ボン酸類、アセトニトリル、アニリン等の窒素化合物、
酢酸エチル等のエステル、アセトン、メチルエチルケト
ン等のケトン類、ジメチルスルホキシド等の硫黄化合物
類より選ばれた1種または2種以上の混合物を利用した
ことを特徴とする請求項6または7または8記載のアレ
ルゲン除去製剤。
9. The organic solvent includes alcohols such as ethanol, methanol and propanol, hydrocarbons such as hexane, toluene and xylene, halogenated hydrocarbons such as chloroform and dichlorobenzene, phenols such as phenol and cresol. , Ethers such as diethyl ether and tetrahydrofuran, carboxylic acids such as acetic acid and oleic acid, nitrogen compounds such as acetonitrile and aniline,
9. One or a mixture of two or more selected from esters such as ethyl acetate, ketones such as acetone and methyl ethyl ketone, and sulfur compounds such as dimethyl sulfoxide is used. Allergen-removing preparation.
【請求項10】 前記有機溶剤は、濃度が20v/v%
〜100v/v%のエタノールを利用したことを特徴と
する請求項6または7または8または9記載のアレルゲ
ン除去製剤。
10. The organic solvent has a concentration of 20 v / v%.
The allergen-removing preparation according to claim 6, 7 or 8 or 9, wherein -100 to 100 v / v% of ethanol is used.
JP22958198A 1998-08-14 1998-08-14 Allergen removal method and preparation Expired - Fee Related JP4247418B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22958198A JP4247418B2 (en) 1998-08-14 1998-08-14 Allergen removal method and preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22958198A JP4247418B2 (en) 1998-08-14 1998-08-14 Allergen removal method and preparation

Publications (2)

Publication Number Publication Date
JP2000063207A true JP2000063207A (en) 2000-02-29
JP4247418B2 JP4247418B2 (en) 2009-04-02

Family

ID=16894432

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22958198A Expired - Fee Related JP4247418B2 (en) 1998-08-14 1998-08-14 Allergen removal method and preparation

Country Status (1)

Country Link
JP (1) JP4247418B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001139479A (en) * 1999-09-01 2001-05-22 Shinto Fine Co Ltd Anti-allergen composition and inactivation of allergen
JP2001322937A (en) * 2000-03-08 2001-11-20 Shinto Fine Co Ltd Antiallergenic composition and method of inactivation for allergen
JP2001328936A (en) * 2000-03-14 2001-11-27 Shinto Fine Co Ltd Antiallergen composition and method for inactivating allergen
JP2001335474A (en) * 2000-05-30 2001-12-04 Fumakilla Ltd Method and preparation for removing allergen
WO2002100995A1 (en) * 2001-06-08 2002-12-19 Kao Corporation Allergen removing agent
JP2003336100A (en) * 2001-07-31 2003-11-28 Kao Corp Allergen remover
EP1538194A1 (en) * 2003-12-02 2005-06-08 Kao Corporation Allergen remover
EP2374858A1 (en) 2005-03-25 2011-10-12 Fumakilla Limited Allergen inactivator
JP2013237803A (en) * 2012-05-16 2013-11-28 Tadashi Inoue Antibacterial agent, anti-allergen agent, and aerosol containing them

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000264837A (en) * 1999-03-17 2000-09-26 Fumakilla Ltd Remover of allergen and removing of allergen utilizing the same
JP5359304B2 (en) * 2008-03-18 2013-12-04 株式会社リコー Image forming apparatus, optical scanning control method, optical scanning control program, and recording medium

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001139479A (en) * 1999-09-01 2001-05-22 Shinto Fine Co Ltd Anti-allergen composition and inactivation of allergen
JP4587537B2 (en) * 1999-09-01 2010-11-24 住化エンビロサイエンス株式会社 Anti-allergen composition and allergen inactivation method
JP2001322937A (en) * 2000-03-08 2001-11-20 Shinto Fine Co Ltd Antiallergenic composition and method of inactivation for allergen
JP2001328936A (en) * 2000-03-14 2001-11-27 Shinto Fine Co Ltd Antiallergen composition and method for inactivating allergen
JP2001335474A (en) * 2000-05-30 2001-12-04 Fumakilla Ltd Method and preparation for removing allergen
JP4659177B2 (en) * 2000-05-30 2011-03-30 フマキラー株式会社 Allergen removal method and preparation
WO2002100995A1 (en) * 2001-06-08 2002-12-19 Kao Corporation Allergen removing agent
JP2003336100A (en) * 2001-07-31 2003-11-28 Kao Corp Allergen remover
EP1538194A1 (en) * 2003-12-02 2005-06-08 Kao Corporation Allergen remover
EP2374858A1 (en) 2005-03-25 2011-10-12 Fumakilla Limited Allergen inactivator
JP2013237803A (en) * 2012-05-16 2013-11-28 Tadashi Inoue Antibacterial agent, anti-allergen agent, and aerosol containing them

Also Published As

Publication number Publication date
JP4247418B2 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
CN104144944B (en) The immunoassay that acid-fast bacilli is infected by anti-LAM antibody and this antibody of use
JP2000063207A (en) Control of allergen and formulation therefor
CN108949750A (en) Extract the method and kit of faeces DNA
CN104792987A (en) Method for diagnosing hepatitis e virus infection and kit
Sakic et al. Immunosuppression prevents neuronal atrophy in lupus-prone mice:: evidence for brain damage induced by autoimmune disease?
JP2537850B2 (en) Manufacturing method of immunoglobulin without retrovirus
Kapasi et al. Morphine stimulates mesangial cell TNF-α and nitrite production
EP0755517B1 (en) A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
CN106290863A (en) A kind of human hepatitis C virus (HCV) saliva/urine antibody colloidal gold detection kit and preparation method thereof
Campbell Serology in the respiratory mycoses
WO2003052144A1 (en) Diagnostic assays for bcwa
CN114409795B (en) Nanometer antibody for detecting diazinon and application thereof
CN108685906A (en) The new opplication of micromolecular compound P7C3
WO2021235176A1 (en) Evaluation method for allergen inactivator and evaluation kit for allergen inactivator
JP4659177B2 (en) Allergen removal method and preparation
JP4292670B2 (en) Immunoassay for anti-HBc antibody
Fields et al. Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage.
Tomar et al. Evaluation of in vitro anti-microbial activity of goat urine peptides
US6346408B1 (en) Method of allophycocyanin inhibition of enterovirus and influenza virus reproduction resulting in cytopathic effect
CN111366564A (en) Time-resolved fluoroimmunoassay kit for measuring malachite green
CN108276470A (en) Cell pyrolysis liquid, the method for extracting intracellular protein, the method and kit for preparing toxoplasma antigen
Van der Veken et al. Immunological methods
CN111323400A (en) Time-resolved fluoroimmunoassay kit for measuring norfloxacin
CN110208411B (en) Carboxylesterase inhibitor formulations for drug metabolism detection
US20240245768A1 (en) Polyclonal Antibodies to Treat Respiratory Syncytial Virus

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080820

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081112

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081120

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081217

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081222

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120123

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130123

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130123

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees